The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $187,606.76 Firm Fixed Price Purchase Order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the emergency mixing of chemotherapy compounds to support VA oncology and infusion treatment programs nationwide. Avella will perform the work at its own facilities while partnering with various VA Veterans Integrated Service...
This contract was awarded by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, to provide compounded chemotherapy agents. The $576,800.00 firm fixed price purchase order has a completion date of January 31, 2019. Avella, a subsidiary of UnitedHealth Group Incorporated, specializes in hazardous sterile compounding and has received numerous prior awards from the VA-VHA to supply customized cancer...
The Department of Veterans Affairs (VA) has awarded a Delivery Order contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $40,000.00 Firm Fixed Price contract is for pharmacy compounding services to support VA oncology and infusion treatment programs nationwide. Avella, which is a 503A certified pharmacy, will leverage its expertise in aseptic techniques for hazardous drug preparation to deliver customized...
The U.S. Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $216,982.32 firm fixed-price definitive contract for compounding services to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract, which has no set-aside designation, was awarded on December 26, 2019 with a completion date of December 25, 2020. As the prime contractor, Avella Specialty Pharmacy will provide specialized...
This federal contract award to Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy) is for chemotherapy compounding services for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $97,052.49 and a performance period running through November 16, 2024. Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated, specializes in compounding customized chemotherapy agents, hazardous sterile preparations,...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a Blanket Purchase Agreement (BPA) call to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. This BPA call, valued at $500,000.00, is for the renewal of a contract to provide chemotherapy compounding services over a one-year period of performance ending on November 16, 2023. Avella will perform the work at its own facilities to support VA...
This federal contract award to Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated, is for PHARMACY COMPOUNDING services valued at $1,105,798.44. The contract supports the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and is a Delivery Order under a Firm Fixed Price contract type. Avella, a 503A certified pharmacy, will provide specialized pharmaceutical compounding services, including chemotherapy...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm-fixed-price purchase order contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $1,875,405.34 contract is for the provision of compounded chemotherapy drugs to support VA oncology and infusion treatment programs at the VA Long Beach Healthcare System in California. The contract period of performance is April 2, 2019 to...
This federal contract award to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is for medication compounding services provided to the Department of Veterans Affairs Veterans Health Administration (VA-VHA). The $424,949.34 firm fixed-price purchase order was awarded on March 4, 2018, with a completion date of May 31, 2018. Avella, a subsidiary of UnitedHealth Group, has received numerous VA-VHA awards for specialized pharmacy services involving chemotherapy and hazardous...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a Firm Fixed Price Purchase Order worth $148,010.43 to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the provision of chemotherapy medication to support VA oncology and infusion treatment programs nationwide. The award does not have a set-aside designation. Optum Pharmacy 801, Inc. has received numerous federal contract...